- Home
- AACB vs NUS Comparison
AACB vs NUS Comparison
Compare AACB & NUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AACB | NUS |
|---|---|---|
| Founded | 2024 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Other Pharmaceuticals |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 286.2M | 343.1M |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | AACB | NUS |
|---|---|---|
| Price | $10.38 | $7.46 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 14.4K | ★ 364.0K |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | N/A | ★ 3.18% |
| EPS Growth | N/A | ★ 207.80 |
| EPS | N/A | ★ 3.18 |
| Revenue | N/A | ★ $3,176,718,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.14 |
| P/E Ratio | ★ N/A | $2.37 |
| Revenue Growth | N/A | ★ 48.98 |
| 52 Week Low | $9.95 | $5.63 |
| 52 Week High | $10.40 | $14.62 |
Technical Indicators
Market Signals| Indicator | AACB | NUS |
|---|---|---|
| Relative Strength Index (RSI) | 58.11 | 44.84 |
| Support Level | $10.31 | $7.03 |
| Resistance Level | N/A | $8.08 |
| Average True Range (ATR) | 0.01 | 0.23 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 66.67 | 10.51 |
Price Performance
Historical ComparisonAbout AACB Artius II Acquisition Inc. Class A Ordinary Shares
Artius II Acquisition Inc is a blank check company.
About NUS Nu Skin Enterprises Inc.
Nu Skin Enterprises Inc develops and distributes a comprehensive line of beauty and wellness solutions in various countries. The company operates in two primary product categories: beauty and wellness products. Additionally, the company also operates through its subsidiary, Rhyz. It reports revenue from nine segments, consisting of its seven geographic Nu Skin segments: Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan and two Rhyz segments: manufacturing, which includes manufacturing and packaging subsidiaries it has acquired; and Rhyz Other, which includes other investments by its Rhyz strategic investment arm. The majority of the company's revenue is generated from the Wellness product category from the Americas segment.